Immediate Impact
36 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Harnessing machine learning to find synergistic combinations for FDA-approved cancer drugs
2024 Standout
Works of Robert C. Osorio being referenced
Dinaciclib, a cyclin-dependent kinase inhibitor, suppresses cholangiocarcinoma growth by targeting CDK2/5/9
2020
Conventional TACE and Drug-Eluting Bead TACE as Locoregional Therapy Before Orthotopic Liver Transplantation
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Robert C. Osorio | 99 | 85 | 60 | 69 | 30 | 285 | |
| Huan Wang | 100 | 44 | 61 | 58 | 30 | 255 | |
| Saba Kiremitçi | 53 | 52 | 48 | 70 | 40 | 253 | |
| Soo Hyun Ahn | 169 | 64 | 112 | 47 | 25 | 321 | |
| Duc Le | 78 | 26 | 32 | 62 | 25 | 283 | |
| Maddalena Grosso | 84 | 32 | 52 | 87 | 31 | 306 | |
| Yueli Tian | 80 | 37 | 77 | 99 | 25 | 334 | |
| Sergio Szvalb | 95 | 46 | 112 | 33 | 30 | 305 | |
| Toshimi Imai | 107 | 86 | 24 | 134 | 30 | 330 | |
| Bole Tian | 189 | 61 | 39 | 51 | 31 | 295 | |
| Fandong Meng | 115 | 29 | 40 | 65 | 31 | 305 |
All Works
Login with ORCID to disown or claim papers
Loading papers...